Filing Flows › Comparisons › DNTH vs CPMD
Dianthus Therapeutics vs Cannapharmarx: DNTH and CPMD compared
Dianthus Therapeutics is the larger company: $284K of revenue in its latest quarter (Q4 2025) against $276K for Cannapharmarx (Q2 2026). Cannapharmarx is growing faster (+19% against -79% a year earlier).
Where the money goes: DNTH and CPMD
Dianthus Therapeutics (DNTH) · Q4 2025
Dianthus Therapeutics, Q4 2025: revenue $284K (-79% year over year), net loss $64.4M, operating cash flow −$47.0M. The chart follows the revenue to costs, profit and cash.
Cannapharmarx (CPMD) · Q2 2026
Cannapharmarx, Q2 2026: revenue $276K (+19% year over year), operating margin -137.1%, net loss $1.9M, operating cash flow −$127K. The chart follows the revenue to costs, profit and cash.
| Dianthus Therapeutics (DNTH) | Cannapharmarx (CPMD) | |
|---|---|---|
| Latest quarter | Q4 2025 | Q2 2026 |
| Revenue | $284K | $276K |
| Revenue growth, Y/Y | -79% | +19% |
| Operating margin | n/m | -137.1% |
| Net earnings | −$64.4M | −$1.9M |
| Net margin | — | -691.1% |
| Operating cash flow | −$47.0M | −$127K |
Questions
Which is bigger, Dianthus Therapeutics or Cannapharmarx?
Dianthus Therapeutics is the larger company: $284K of revenue in its latest quarter (Q4 2025) against $276K for Cannapharmarx (Q2 2026).
Is Dianthus Therapeutics or Cannapharmarx growing faster?
Cannapharmarx is growing faster (+19% against -79% a year earlier).
More: Dianthus Therapeutics earnings · how Dianthus Therapeutics makes money · Cannapharmarx earnings · how Cannapharmarx makes money
From the companies' latest 10-Q, 10-K or earnings release (10-K filed Mar 9, 2026; 10-Q filed Aug 18, 2026). Fiscal quarters can end on different dates. Not investment advice.